These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics. Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107 [TBL] [Abstract][Full Text] [Related]
23. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles. Nasiri Kenari A; Cheng L; Hill AF Methods; 2020 May; 177():103-113. PubMed ID: 31917274 [TBL] [Abstract][Full Text] [Related]
24. Quantitative and functional characterisation of extracellular vesicles after passive loading with hydrophobic or cholesterol-tagged small molecules. Tréton G; Sayer C; Schürz M; Jaritsch M; Müller A; Matea CT; Stanojlovic V; Melo-Benirschke H; Be C; Krembel C; Rodde S; Haffke M; Hintermann S; Marzinzik A; Ripoche S; Blöchl C; Hollerweger J; Auer D; Cabrele C; Huber CG; Hintersteiner M; Wagner T; Lingel A; Meisner-Kober N J Control Release; 2023 Sep; 361():694-716. PubMed ID: 37567507 [TBL] [Abstract][Full Text] [Related]
25. A Systematic Evaluation of Factors Affecting Extracellular Vesicle Uptake by Breast Cancer Cells. Stranford DM; Hung ME; Gargus ES; Shah RN; Leonard JN Tissue Eng Part A; 2017 Nov; 23(21-22):1274-1282. PubMed ID: 28586292 [TBL] [Abstract][Full Text] [Related]
26. Proteomic characterization of macro-, micro- and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication. Tong M; Kleffmann T; Pradhan S; Johansson CL; DeSousa J; Stone PR; James JL; Chen Q; Chamley LW Hum Reprod; 2016 Apr; 31(4):687-99. PubMed ID: 26839151 [TBL] [Abstract][Full Text] [Related]
27. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer. Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471 [TBL] [Abstract][Full Text] [Related]
28. Flow cytometric analysis of extracellular vesicle subsets in plasma: impact of swarm by particles of non-interest. Libregts SFWM; Arkesteijn GJA; Németh A; Nolte-'t Hoen ENM; Wauben MHM J Thromb Haemost; 2018 Jul; 16(7):1423-1436. PubMed ID: 29781099 [TBL] [Abstract][Full Text] [Related]
29. Production of Extracellular Vesicles Loaded with Therapeutic Cargo. Lamichhane TN; Jay SM Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423 [TBL] [Abstract][Full Text] [Related]
30. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives. Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664 [TBL] [Abstract][Full Text] [Related]
31. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807 [TBL] [Abstract][Full Text] [Related]
32. Bioimaging of metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). Becker JS; Zoriy M; Matusch A; Wu B; Salber D; Palm C; Becker JS Mass Spectrom Rev; 2010; 29(1):156-75. PubMed ID: 19557838 [TBL] [Abstract][Full Text] [Related]
33. Fast chemical imaging at high spatial resolution by laser ablation inductively coupled plasma mass spectrometry. Wang HA; Grolimund D; Giesen C; Borca CN; Shaw-Stewart JR; Bodenmiller B; Günther D Anal Chem; 2013 Nov; 85(21):10107-16. PubMed ID: 23957530 [TBL] [Abstract][Full Text] [Related]
35. Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines. Nannizzi S; Veal GJ; Giovannetti E; Mey V; Ricciardi S; Ottley CJ; Del Tacca M; Danesi R Cancer Chemother Pharmacol; 2010 Aug; 66(3):547-58. PubMed ID: 20020129 [TBL] [Abstract][Full Text] [Related]
36. Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116. Tippayamontri T; Kotb R; Paquette B; Sanche L Invest New Drugs; 2011 Dec; 29(6):1321-7. PubMed ID: 20658169 [TBL] [Abstract][Full Text] [Related]
37. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles. Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585 [TBL] [Abstract][Full Text] [Related]
38. Mapping Subpopulations of Cancer Cell-Derived Extracellular Vesicles and Particles by Nano-Flow Cytometry. Choi D; Montermini L; Jeong H; Sharma S; Meehan B; Rak J ACS Nano; 2019 Sep; 13(9):10499-10511. PubMed ID: 31469961 [TBL] [Abstract][Full Text] [Related]
39. Mass spectrometry study of hemoglobin-oxaliplatin complexes in colorectal cancer patients and potential association with chemotherapeutic responses. Mandal R; Sawyer MB; Li XF Rapid Commun Mass Spectrom; 2006; 20(17):2533-8. PubMed ID: 16878345 [TBL] [Abstract][Full Text] [Related]